Organogenesis
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Organogenesis and other ETFs, options, and stocks.About ORGO
Organogenesis Holdings, Inc. is a regenerative medical company, which engages in the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. The company was founded in 1985 and is headquartered in Canton, MA.
CEOGary S. Gillheeney
CEOGary S. Gillheeney
Employees869
Employees869
HeadquartersCanton, Massachusetts
HeadquartersCanton, Massachusetts
Founded1985
Founded1985
Employees869
Employees869
ORGO Key Statistics
Market cap503.84M
Market cap503.84M
Price-Earnings ratio-40.47
Price-Earnings ratio-40.47
Dividend yield—
Dividend yield—
Average volume974.23K
Average volume974.23K
High today$4.00
High today$4.00
Low today$3.84
Low today$3.84
Open price$3.90
Open price$3.90
Volume763.51K
Volume763.51K
52 Week high$7.08
52 Week high$7.08
52 Week low$2.61
52 Week low$2.61
Stock Snapshot
With a market cap of 503.84M, Organogenesis(ORGO) trades at $3.97. The stock has a price-to-earnings ratio of -40.47.
During the trading session on 2026-01-16, Organogenesis(ORGO) shares reached a daily high of $4.00 and a low of $3.84. At a current price of $3.97, the stock is +3.4% higher than the low and still -0.6% under the high.
Trading activity shows a volume of 763.51K, compared to an average daily volume of 974.23K.
The stock's 52-week range extends from a low of $2.61 to a high of $7.08.
The stock's 52-week range extends from a low of $2.61 to a high of $7.08.
ORGO News
Simply Wall St 5d
Is Organogenesis Holdings In A Good Position To Invest In Growth?Just because a business does not make any money, does not mean that the stock will go down. For example, although software-as-a-service business Salesforce.com...
People also own
Based on the portfolios of people who own ORGO. This list is generated using Robinhood data, and it’s not a recommendation.